Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients

S. Toma, L. Repetto, A. Giacchero, T. Coialbu, M. Costantini, G. F. Addamo, F. Guido, R. Rosso

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

147 stage II pre- and perimenopausal breast cancer patients were treated with cyclophosphamide-methotrexate-5-fluorouracil (CMF)- based adjuvant regimens. 103 (72%) patients became amenorrheic during or immediately after the end of the chemotherapy program. Univariate analyses for age, menstrual status, nodal involvement, grading, estrogen and progesterone receptor status indicated no correlation between induction of amenorrhea and a significant prolongation of overall and disease-free survival. Multivariate analyses confirmed that young age at diagnosis, increasing number of infiltrated nodes, negative progesterone receptor status and grade 3 tumors are associated with a worse prognosis. Our results suggest that no benefit is expected in women with drug induced amenorrhea after CMF adjuvant treatment.

Original languageEnglish
Pages (from-to)321-325
Number of pages5
JournalJournal of Chemotherapy
Volume4
Issue number5
Publication statusPublished - 1992

Fingerprint

Amenorrhea
Progesterone Receptors
Methotrexate
Fluorouracil
Cyclophosphamide
Breast Neoplasms
Drug Therapy
Estrogen Receptors
Disease-Free Survival
Multivariate Analysis
Pharmaceutical Preparations
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)

Cite this

Toma, S., Repetto, L., Giacchero, A., Coialbu, T., Costantini, M., Addamo, G. F., ... Rosso, R. (1992). Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients. Journal of Chemotherapy, 4(5), 321-325.

Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients. / Toma, S.; Repetto, L.; Giacchero, A.; Coialbu, T.; Costantini, M.; Addamo, G. F.; Guido, F.; Rosso, R.

In: Journal of Chemotherapy, Vol. 4, No. 5, 1992, p. 321-325.

Research output: Contribution to journalArticle

Toma, S. ; Repetto, L. ; Giacchero, A. ; Coialbu, T. ; Costantini, M. ; Addamo, G. F. ; Guido, F. ; Rosso, R. / Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients. In: Journal of Chemotherapy. 1992 ; Vol. 4, No. 5. pp. 321-325.
@article{9872c346790141ecbd6ee9b82aab4255,
title = "Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients",
abstract = "147 stage II pre- and perimenopausal breast cancer patients were treated with cyclophosphamide-methotrexate-5-fluorouracil (CMF)- based adjuvant regimens. 103 (72{\%}) patients became amenorrheic during or immediately after the end of the chemotherapy program. Univariate analyses for age, menstrual status, nodal involvement, grading, estrogen and progesterone receptor status indicated no correlation between induction of amenorrhea and a significant prolongation of overall and disease-free survival. Multivariate analyses confirmed that young age at diagnosis, increasing number of infiltrated nodes, negative progesterone receptor status and grade 3 tumors are associated with a worse prognosis. Our results suggest that no benefit is expected in women with drug induced amenorrhea after CMF adjuvant treatment.",
author = "S. Toma and L. Repetto and A. Giacchero and T. Coialbu and M. Costantini and Addamo, {G. F.} and F. Guido and R. Rosso",
year = "1992",
language = "English",
volume = "4",
pages = "321--325",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",
number = "5",

}

TY - JOUR

T1 - Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patients

AU - Toma, S.

AU - Repetto, L.

AU - Giacchero, A.

AU - Coialbu, T.

AU - Costantini, M.

AU - Addamo, G. F.

AU - Guido, F.

AU - Rosso, R.

PY - 1992

Y1 - 1992

N2 - 147 stage II pre- and perimenopausal breast cancer patients were treated with cyclophosphamide-methotrexate-5-fluorouracil (CMF)- based adjuvant regimens. 103 (72%) patients became amenorrheic during or immediately after the end of the chemotherapy program. Univariate analyses for age, menstrual status, nodal involvement, grading, estrogen and progesterone receptor status indicated no correlation between induction of amenorrhea and a significant prolongation of overall and disease-free survival. Multivariate analyses confirmed that young age at diagnosis, increasing number of infiltrated nodes, negative progesterone receptor status and grade 3 tumors are associated with a worse prognosis. Our results suggest that no benefit is expected in women with drug induced amenorrhea after CMF adjuvant treatment.

AB - 147 stage II pre- and perimenopausal breast cancer patients were treated with cyclophosphamide-methotrexate-5-fluorouracil (CMF)- based adjuvant regimens. 103 (72%) patients became amenorrheic during or immediately after the end of the chemotherapy program. Univariate analyses for age, menstrual status, nodal involvement, grading, estrogen and progesterone receptor status indicated no correlation between induction of amenorrhea and a significant prolongation of overall and disease-free survival. Multivariate analyses confirmed that young age at diagnosis, increasing number of infiltrated nodes, negative progesterone receptor status and grade 3 tumors are associated with a worse prognosis. Our results suggest that no benefit is expected in women with drug induced amenorrhea after CMF adjuvant treatment.

UR - http://www.scopus.com/inward/record.url?scp=0026489498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026489498&partnerID=8YFLogxK

M3 - Article

C2 - 1479423

AN - SCOPUS:0026489498

VL - 4

SP - 321

EP - 325

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

IS - 5

ER -